Tag: Candidate

Latest News

MODAG Successfully Completes Phase 1 Study of their Lead Candidate Anle138b and Receives Additional USD 1.4 Million from Michael J. Fox Foundation

Newsemia
WENDELSHEIM, Germany–(BUSINESS WIRE)–MODAG, a German biotechnology company focused on the development of disease-modifying small molecule therapeutics for neurodegenerative diseases, today announced the successful completion of...
Latest News

Stabilized prefusion spike vaccine candidate induces powerful immune response

Newsemia
A new research paper by scientists at Janssen Vaccines & Prevention BV, in the Netherlands and published on the preprint server bioRxiv* is based on...
Cardiology

Identification of novel candidate genes in heterotaxy syndrome patients with congenital heart diseases by whole exome sequencing.

Newsemia
Identification of novel candidate genes in heterotaxy syndrome patients with congenital heart diseases by whole exome sequencing. Biochim Biophys Acta Mol Basis Dis. 2020 Jul...
Pharma / Biotech

Discovery of a novel 9-position modified second-generation anti-HCV candidate via bioconversion and semi-synthesis of FR901459.

Newsemia
Discovery of a novel 9-position modified second-generation anti-HCV candidate via bioconversion and semi-synthesis of FR901459. Bioorg Med Chem Lett. 2020 Jul 21;30(18):127423 Authors: Makino T,...
Latest News

Novel drug candidate offers a major advance in the treatment for diabetes

Newsemia
The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that offers a major advance in the treatment for diabetes....
Biology

Genetically modified non-human primate fetuses as models to study the role of candidate genes for increasing size and folding of the human neocortex during development and evolution

Newsemia
By Michael Heide and Wieland B. Huttner   Introduction The neocortex is the seat of our higher cognitive abilities that distinguish us from other mammals...
Latest News

Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate

Newsemia
Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines,...
Latest News

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Newsemia
Now, a new Israeli study published on the preprint server bioRxiv in June 2020 reports a new recombinant vaccine expressing the S or spike protein...
Latest News

Coronavirus Vaccine Trials In China Show Promise

Newsemia
We all know that the coronavirus pandemic can’t be fully stopped unless there’s a vaccine. Thankfully, a new update reveals that a Chinese pharmaceutical company...
Latest News

Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19

Newsemia
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive preliminary results of...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World